Eosinofilia sinovial

Caritina Vázquez-Triñanes , Bernardo Sopeña
{"title":"Eosinofilia sinovial","authors":"Caritina Vázquez-Triñanes ,&nbsp;Bernardo Sopeña","doi":"10.1016/j.semreu.2012.04.001","DOIUrl":null,"url":null,"abstract":"<div><p>Synovial fluid eosinophilia is defined as the presence of eosinophils, irrespective of quantity, in the synovial fluid and is a rare finding that is probably underestimated. The pathogenesis of this entity remains incompletely understood. Secondary and idiopathic forms have been described. Idiopathic forms are those not associated with systemic or rheumatic inflammatory disease or associated with chronic non-inflammatory rheumatic diseases. Idiopathic forms can be divided into pure or pseudoallergic forms when they occur in patients with an atopic background and/or intensely positive dermographism. Both forms are usually monoarthritis of the large joints with a substantial component of joint effusion but few inflammatory signs. Synovial fluid usually contains between 2,000 and 10,000<!--> <!-->leukocytes/mm<sup>3</sup>, with a variable percentage of eosinophils. Although a major form (&gt;10% eosinophils) and a minor form (&lt;10% eosinophils) have been distinguished, both seem to have the same significance in terms of clinical manifestations and prognosis. Peripheral eosinophilia (&gt;600<!--> <!-->eosinophils/mm<sup>3</sup>) is a rare association and is not usually severe. Symptoms resolve within a few days without specific therapy and recurrences occur in approximately half of patients. Non-steroidal anti-inflammatory drugs are usually sufficient to control symptoms. Synovial fluid eosinophilia has not been associated with the development of new joint deformities nor has it been described as a chronic form of arthritis.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"13 3","pages":"Pages 110-113"},"PeriodicalIF":0.0000,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2012.04.001","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminarios de la Fundación Espa?ola de Reumatología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1577356612000231","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Synovial fluid eosinophilia is defined as the presence of eosinophils, irrespective of quantity, in the synovial fluid and is a rare finding that is probably underestimated. The pathogenesis of this entity remains incompletely understood. Secondary and idiopathic forms have been described. Idiopathic forms are those not associated with systemic or rheumatic inflammatory disease or associated with chronic non-inflammatory rheumatic diseases. Idiopathic forms can be divided into pure or pseudoallergic forms when they occur in patients with an atopic background and/or intensely positive dermographism. Both forms are usually monoarthritis of the large joints with a substantial component of joint effusion but few inflammatory signs. Synovial fluid usually contains between 2,000 and 10,000 leukocytes/mm3, with a variable percentage of eosinophils. Although a major form (>10% eosinophils) and a minor form (<10% eosinophils) have been distinguished, both seem to have the same significance in terms of clinical manifestations and prognosis. Peripheral eosinophilia (>600 eosinophils/mm3) is a rare association and is not usually severe. Symptoms resolve within a few days without specific therapy and recurrences occur in approximately half of patients. Non-steroidal anti-inflammatory drugs are usually sufficient to control symptoms. Synovial fluid eosinophilia has not been associated with the development of new joint deformities nor has it been described as a chronic form of arthritis.

滑膜嗜酸性粒细胞增多症
滑膜液嗜酸性粒细胞增多被定义为存在嗜酸性粒细胞,不论数量,在滑膜液中,是一种罕见的发现,可能被低估。这种疾病的发病机制尚不完全清楚。已经描述了继发性和特发性形式。特发性形式是那些与系统性或风湿性炎症疾病无关或与慢性非炎症性风湿病相关的形式。当特发性形式发生在具有特应性背景和/或强烈阳性人口统计学的患者中时,可分为纯粹或假过敏形式。这两种形式通常都是大关节的单关节炎,有大量关节积液,但很少有炎症体征。滑液通常含有2,000至10,000个白细胞/mm3,并含有不同百分比的嗜酸性粒细胞。虽然已经区分了主要形式(>10%嗜酸性粒细胞)和次要形式(<10%嗜酸性粒细胞),但两者在临床表现和预后方面似乎具有相同的意义。外周嗜酸性粒细胞增多(600嗜酸性粒细胞/mm3)是一种罕见的关联,通常不严重。无需特殊治疗,症状可在几天内消退,大约一半的患者会复发。非甾体类抗炎药通常足以控制症状。滑膜液嗜酸性粒细胞增多症与新关节畸形的发展没有关联,也没有被描述为关节炎的一种慢性形式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信